Literature DB >> 23153961

High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis.

Yang Liu1, Kolja M Knapp, Liang Yang, Søren Molin, Henrik Franzyk, Anders Folkesson.   

Abstract

An array of β-peptoid-peptide hybrid oligomers displaying different amino acid/peptoid compositions and chain lengths was studied with respect to antimicrobial activity against Staphylococcus epidermidis both in planktonic and biofilm cultures, comparing the effects with those of the common antibiotic vancomycin. Susceptibility and time-kill assays were performed to investigate activity against planktonic cells, whilst confocal laser scanning microscopy was used to investigate the dynamics of the activity against cells within biofilms. All tested peptidomimetics were bactericidal against both exponentially growing and stationary-phase S. epidermidis cells with similar killing kinetics. At the minimum inhibitory concentration (MIC), all peptidomimetics inhibited biofilm formation, whilst peptidomimetics at concentrations above the MIC (80-160μg/mL) eradicated young (6-h-old) biofilms, whilst even higher concentrations were needed to eradicate mature (24-h-old) biofilms completely. Chiral and guanidinylated hybrids exhibited the fastest killing effects against slow-growing cells and had more favourable antibiofilm properties than analogues only containing lysine or lacking chirality in the β-peptoid residues. However, the results of the mature biofilm killing assay indicated more complex structure-activity relationships. Cytotoxicity assays showed a clear correlation between oligomer length and cell toxicity within each subclass of peptides, but all possessed a high differential toxicity favouring killing of bacterial cells. This class of peptidomimetics may constitute promising antimicrobial alternatives for the prevention and treatment of multidrug-resistant S. epidermidis infections.
Copyright © 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153961     DOI: 10.1016/j.ijantimicag.2012.09.014

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  15 in total

1.  Antibacterial mechanism of high-mobility group nucleosomal-binding domain 2 on the Gram-negative bacteria Escherichia coli.

Authors:  Heng Li; Xiao-Fei Shen; Xin-E Zhou; Yan-E Shi; Lu-Xia Deng; Yi Ma; Xiao-Ying Wang; Jing-Yu Li; Ning Huang
Journal:  J Zhejiang Univ Sci B       Date:  2017-05       Impact factor: 3.066

2.  N-terminally modified linear and branched spermine backbone dipeptidomimetics against planktonic and sessile methicillin-resistant Staphylococcus aureus.

Authors:  Rikeshwer Prasad Dewangan; Seema Joshi; Shalini Kumari; Hemlata Gautam; Mohammed Shahar Yar; Santosh Pasha
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 3.  Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs.

Authors:  Natalia Molchanova; Paul R Hansen; Henrik Franzyk
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411

4.  Functional Mechanism of Antimicrobial Peptide Bomidin and Its Safety for Macrobrachium rosenbergii.

Authors:  Miao Zhang; Youli Yu; Lele Lian; Wanjun Li; Jianluan Ren; Ying Liang; Feng Xue; Fang Tang; Xiaohua Zhu; Jianqun Ling; Jianjun Dai
Journal:  Probiotics Antimicrob Proteins       Date:  2021-10-12       Impact factor: 4.609

5.  The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.

Authors:  André Holdfeldt; Sarah Line Skovbakke; Malene Winther; Michael Gabl; Christina Nielsen; Iris Perez-Gassol; Camilla Josephine Larsen; Ji Ming Wang; Anna Karlsson; Claes Dahlgren; Huamei Forsman; Henrik Franzyk
Journal:  J Biol Chem       Date:  2016-07-15       Impact factor: 5.157

Review 6.  Peptides and Peptidomimetics for Antimicrobial Drug Design.

Authors:  Biljana Mojsoska; Håvard Jenssen
Journal:  Pharmaceuticals (Basel)       Date:  2015-07-13

7.  Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase.

Authors:  Rasmus Bojsen; Birgitte Regenberg; Anders Folkesson
Journal:  BMC Microbiol       Date:  2014-12-04       Impact factor: 3.605

8.  Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides.

Authors:  Ammar Almaaytah; Ya'u Ajingi; Ahmad Abualhaijaa; Shadi Tarazi; Nizar Alshar'i; Qosay Al-Balas
Journal:  Infect Drug Resist       Date:  2016-12-29       Impact factor: 4.003

9.  Peptide/β-Peptoid Hybrids with Activity against Vancomycin-Resistant Enterococci: Influence of Hydrophobicity and Structural Features on Antibacterial and Hemolytic Properties.

Authors:  Martin Vestergaard; Bolette Skive; Ilona Domraceva; Hanne Ingmer; Henrik Franzyk
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

10.  The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner.

Authors:  Rasmus Bojsen; Rasmus Torbensen; Camilla Eggert Larsen; Anders Folkesson; Birgitte Regenberg
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.